AZD6244, 50 mg

AZD6244, 50 mg — Enhanced description: MEK1/2 inhibitor (selumetinib) supplied by STEMCELL Technologies as a 50 mg solid for research applications. Intended for in vitro studies of the MAPK/ERK signaling cascade and pathway modulation. Manufacturer: STEMCELL Technologies. For research use only. Refer to the manufacturer's datasheet for solubility advice, handling precautions, storage and suggested assay conditions.